Skip to main content

Table 1 Baseline demographic, clinical and treatment characteristics of patient population

From: Coronavirus disease 19 in minority populations of Newark, New Jersey

VariableOverall (n = 251)Survivors (n = 154)Non-survivors (n = 97)p value
Age (years) (m, IQR)62 (49–74)58 (46–69)68 (56–77)< 0.0001
Sex (Male)129 (51)69 (45)60 (62)0.008
Race
 African American210 (84)122 (79)88 (91)0.013
 Hispanic41 (16)32 (21)9 (9)
BMI (kg/m2)
  < 2548 (19)27 (18)21 (22)0.445
 25–29.983 (33)48 (31)35 (36)
 30–3561 (24)38 (25)23 (24)
  > 3559 (24)41 (27)18 (19)
Insurance Status
 Commercial113 (45)67 (44)46 (47)0.655
 Medicare/Medicaid86 (35)52 (34)34 (35)
 Charity Care/Uninsured51 (20)34 (22)17 (18)
Self-reported exposure
 Yes65 (26)39 (25)26 (27)0.795
History of
 Hypertension175 (70)98 (66)77 (80)0.016
 Diabetes Mellitus115 (46)65 (45)50 (52)0.269
 CAD49 (20)20 (14)29 (30)0.003
 CHF50 (20)25 (17)25 (26)0.095
 CVA28 (11)12 (9)16 (16)0.056
 COPD23 (9)13 (9)10 (10)0.754
 HIV13 (5)12 (8)1 (1)0.008
 CKD46 (18)17 (12)29 (30)0.005
 Malignancy22 (9)8 (6)14 (14)0.021
Duration of Symptoms (d)4 (2–7)4 (3–7)3 (2–7)0.189
Vital signs at the time of presentation
 Fever (> 100.4F)143 (57)89 (58)54 (56)0.741
 HR > 125 bpm16 (6)6 (6)10 (6)0.922
 RR > 24 bpm55 (22)28 (29)27 (18)0.036
 MAP < 659 (4)3 (3)6 (4)0.922
Chest Imaging features
 Consolidation48 (19)27 (22)21 (22)0.509
 Ground glass Opacities136 (54)87 (56)49 (51)0.385
 Bilateral Infiltrates192 (76)122 (79)70 (73)0.271
Treatment
 Chloroquine186 (74)102 (72)84 (92)0.001
 Remdesivir2 (1)2 (2)0 (0)0.157
 Steroids35 (14)9 (6)26 (28)< 0.001
 Tociluzumab39 (16)16 (12)23 (28)0.002
 *Antibiotics204 (81)118 (77)86 (91)0.004
  1. M: Median; IQR: Interquartile range; CAD: Coronary artery disease; CHF: Congestive Heart Failure; CVA: Cerebrovascular Accident; COPD: Chronic Obstructive Lung Disease; HIV: Human Immune Deficiency virus; CKD: Chronic Kidney Disease; d: days; HR: Heart Rate; bpm: beats/breaths per minute; RR: Respiratory Rate; MAP: Mean Artery Pressure; *Anti-bacterial medications used in this category included azithromycin, ceftriaxone and doxycycline